Unipr AI Agents

THE PROBLEM:

You're launching a high-stakes program. The board demands competitive positioning. Finance needs realistic budgets. Your PMO wants clear boundaries. Everyone wants it yesterday. Meanwhile, you're buried in execution while trying to research competitors, validate regulatory pathways, and build a defensible business case from scratch.

WHAT SCOPER DELIVERS:

• Competitive Intelligence – Positions your project against market alternatives and identifies clear differentiation opportunities.
• Regulatory Pathway Mapping – Provides realistic timelines grounded in current FDA/EMA guidance and recent approval precedents.
• Resource Benchmarking – Estimates budgets and schedules using industry data from comparable programs, not outdated templates.
• Evidence-Based Documentation – Generates board-ready scopes with cited sources that withstand executive scrutiny.

THE OUTCOME:

Board-ready strategic scope in 48 hours, not 3 weeks. Your charter includes the competitive analysis and regulatory intelligence leadership expects. You enter funding discussions with defensible assumptions grounded in current market reality—no scrambling, no guesswork.

WHO SCOPER HELPS:

Portfolio VPs and Program Heads launching new initiatives who need investor-grade scopes that secure funding and align stakeholders—without the research burden.

THE PROBLEM:

You have leadership approval, funding is secured, and stakeholders are aligned. Now you need a detailed execution plan—complete with task breakdown, resource allocation across functions, realistic timelines, and dependency mapping. Your teams are waiting to start, but building a comprehensive WBS manually means 2-4 weeks grinding through generic templates and chasing subject matter experts.

WHAT BUILDER DELIVERS:

• Intelligent Task Decomposition – Breaks complex scopes into comprehensive work packages with appropriate detail across all project phases.
• Resource Allocation by Function, Role, and Skills – Maps which teams do what, identifies skill requirements, and estimates FTE needs across your organization.
• Industry-Benchmarked Scheduling – Builds realistic timelines based on current regulatory requirements and execution precedents, not template guesswork.
• Dependency and Priority Mapping – Identifies critical path activities, prerequisites, and interdependencies to prevent execution bottlenecks.

THE OUTCOME:

Execution-ready plan delivered in 48 hours with 200+ activities, clear ownership across functions, realistic timelines, and budget allocation. Your PMO starts execution immediately with a roadmap that accounts for regulatory milestones, resource constraints, and cross-functional dependencies. Day one begins with clarity, not confusion.

WHO BUILDER HELPS:

Program Directors and Project Managers who need comprehensive, execution-ready plans that align cross-functional teams and withstand PMO scrutiny—without the planning burden.

THE PROBLEM:

Your project plan looks solid, but leadership knows circumstances evolve constantly. Regulatory timelines shift. Patient enrollment disappoints. Competitors move faster than expected. Supply chains get disrupted. Budget constraints tighten. Yet you're executing a single-path plan with no alternatives ready when conditions change. By the time you react, you're already behind.

WHAT MAPPER DELIVERS:

• Multi-Scenario Development – Generates 3 pathway alternatives tailored to different market conditions, risk profiles, and resource constraints.
• Probability and Impact Scoring – Assesses likelihood and business impact of each scenario based on current industry conditions and regulatory precedents.
• Switching Criteria Definition – Identifies specific triggers that signal when to pivot from one scenario to another before it's too late.
• Execution-Ready Alternatives – Converts each scenario into detailed WBS modifications with timeline adjustments and resource reallocations.

THE OUTCOME:

Three scenarios delivered with clear switching criteria and execution plans. Your leadership team evaluates the cheapest path, the fastest route, or the highest pTRS option in the face of scientific uncertainties and evolving conditions. When the inevitable change happens, you pivot with prepared contingencies while competitors scramble. Your program adapts, theirs stall.

WHO MAPPER HELPS:

Portfolio VPs and Program Directors navigating scientific uncertainties and dynamic markets who need optionality built into execution—not retrofitted after the fact.

THE PROBLEM:

You're evaluating multiple paths forward—different clinical strategies, partnership structures, market entry approaches, or platform investments. Each option has champions. Every meeting surfaces new opinions. But leadership needs objective analysis grounded in market evidence, not internal politics or gut feel. Making the wrong choice costs years and millions. Making no choice costs just as much.

WHAT COMPARER DELIVERS:

• Systematic Multi-Criteria Evaluation – Compares alternatives across financial impact, technical feasibility, competitive positioning, regulatory pathway, and strategic fit.
• Evidence-Based Benchmarking – Grounds each comparison in industry precedents, competitive intelligence, and regulatory approval data—not assumptions.
• Trade-Off Analysis – Quantifies what you gain and sacrifice with each option, making invisible costs visible before commitment.
• Clear Recommendations – Delivers ranked alternatives with explicit rationale tied to your priorities and risk tolerance.

THE OUTCOME:

Objective comparison delivered with evidence from competitive precedents, regulatory benchmarks, and market intelligence. Decision meetings shift from opinion exchanges to evidence review. The recommended path comes with clear justification that withstands board scrutiny. You make the call with confidence, not consensus-seeking paralysis.

WHO COMPARER HELPS:

Executive teams and Portfolio VPs evaluating critical alternatives who need objective analysis to break decision gridlock—without months of consulting studies.

THE PROBLEM:

Your program is underway. Then the unexpected happens. A critical dependency you didn't map blocks execution. Resource constraints you didn't anticipate create bottlenecks. Budget pressures compound across phases. Scope assumptions prove unrealistic. Your team is fire-fighting instead of executing. Leadership questions why risks weren't identified earlier. Most risk registers are generic checklists that identify problems after they've materialized. You need early warning systems, not hindsight.

WHAT MITIGATOR DELIVERS:

• Comprehensive Risk Detection – Systematically scans your plan for execution risks across scope, timing, resources, and budget before they surface.
• Probability and Impact Assessment – Scores each risk by likelihood and business impact, so you know what demands attention now vs. monitoring.
• Evidence-Based Mitigation Strategies – Recommends proven approaches drawn from regulatory precedent and industry best practices, not generic advice.
• Prioritized Risk Register – Delivers P1/P2/P3 risks ranked by criticality with specific actions to prevent or minimize impact.

THE OUTCOME:

Execution risks are identified before they derail momentum. Your team knows which risks are critical (P1), which need monitoring (P2), and which are acceptable (P3). Mitigation strategies are specific and actionable—proven approaches, not platitudes. Governance meetings shift from "why didn't we see this?" to "here's how we're preventing it." Your program navigates execution challenges while competitors stumble.

WHO MITIGATOR HELPS:

Program Directors and PMO Leaders who refuse to let preventable risks derail execution—protecting timeline, budget, and objectives.

THE PROBLEM:

You're launching a multi-site clinical program across three continents. You need senior regulatory expertise starting in Q2, clinical operations support in Q3, and data management skills in Q4. You're scrolling through org charts and asking functional leaders "who's available?" You don't know who's overloaded on other projects, who's on holiday in Q3, who has the right experience, or who wants to develop these skills for career growth. You assign based on who you know and who responds to your email. The result? Mismatched assignments leading to quality issues, burnout, and wasted talent.

WHAT ALLOCATOR DELIVERS:

• Intelligent People Matching – Integrates with HR and project systems to match task requirements against skills, experience, availability, and career aspirations across your global organization.
• Real-Time Availability Tracking – Monitors who's working on what, when they're finishing, vacation schedules, and workload across all active projects—not guesswork.
• Career Development Integration – Considers growth aspirations so people develop new skills and advance their careers, not repeat the same tasks indefinitely.
• Workload Optimization – Balances assignments to prevent burnout, avoid underutilization, and ensure sustainable team productivity across time zones.

THE OUTCOME:

Resource decisions are data-driven, not gut-feel. Your critical regulatory task goes to someone with the right experience, availability, AND career interest in that work. Team members grow through strategic assignments instead of repeating the same tasks. Workload is optimized globally—no one is burning out while others are underutilized. Quality improves because the right people do work they're equipped for and motivated to excel at.

WHO ALLOCATOR HELPS:

PMO Leaders and Resource Managers managing global teams across dozens of projects who need intelligent, data-driven resource allocation—not assignment guesswork.

THE PROBLEM:

Your program sailed through stage gates until the FDA raised concerns during pre-submission. Quality issues you thought were minor prove critical. Compliance gaps you didn't know existed threaten approval timelines. Governance reviews checked boxes but missed risks. Leadership asks why no one saw this coming. You need early warning systems that detect execution problems before they become crises—not governance theater that documents failures after the fact.

WHAT GOVERNOR DELIVERS:

• HealthCheck Intelligence – Applies NASA/DARPA governance methodologies to assess project health across quality, compliance, execution, and strategic alignment dimensions.
• Regulatory Compliance Validation – Evaluates your program against current FDA/EMA requirements and recent inspection findings to identify gaps before agencies do.
• Industry Benchmark Comparison – Positions your project performance against comparable programs to identify where you're falling behind or leading.
• Failure Pattern Detection – Recognizes early warning signs from industry precedent that predict downstream failures—while you can still course-correct.

THE OUTCOME:

Governance reviews shift from status reporting to strategic intervention. Your quality and compliance risks are identified months before they derail execution. Leadership sees evidence-based recommendations grounded in regulatory precedent and industry benchmarks. You catch the quality issue in Phase 1, not Phase 3. Governance becomes your competitive advantage, not bureaucratic overhead.

WHO GOVERNOR HELPS:

Program Directors and Quality Leaders who refuse to let preventable governance failures derail programs—protecting investment, timelines, and regulatory standing.

THE PROBLEM:

You're six months into execution when circumstances shift. A competitor announces breakthrough data. Regulatory pathways evolve. Budget priorities change. Scientific results surprise. Your original plan was sound, but it's based on assumptions that no longer hold. You know adaptation is needed, but you lack the bandwidth to determine what should change and why. Rebuilding from scratch isn't an option—you need intelligent modification of what's already in flight.

WHAT ENRICHER DELIVERS:

• Current Conditions Assessment – Evaluates your in-flight plan against today's competitive landscape, regulatory environment, and market realities—not when you started.
• Gap and Opportunity Identification – Identifies where your plan is outdated, where competitors have moved ahead, and where new efficiencies are available.
• Prioritized Adaptation Recommendations – Delivers P1/P2/P3/P4 modifications ranked by impact, so you know what changes matter most right now.
• Proactive Roadblock Detection – Spots emerging risks and execution barriers before you hit them, recommending course corrections while you still have options.

THE OUTCOME:

Your plan adapts intelligently to current conditions without starting over. Critical P1 changes are clear—the modifications that keep you competitive and on track. Your team implements targeted improvements, not wholesale redesign. Vigilant program leaders use Enricher frequently to maintain proactive posture as markets shift.

WHO ENRICHER HELPS:

Program Directors managing initiatives in motion who need their plans to evolve with changing conditions—not remain frozen to outdated assumptions.

THE PROBLEM:

Your PMO sends 47-slide dashboards no one reads. Strategic documents pile up without analysis. Portfolio reviews recycle the same spreadsheets. You have data everywhere—project plans, clinical documents, budget trackers, regulatory filings—but zero strategic synthesis. When leadership asks: So what? How do we compare to competitors? Where are the portfolio optimization opportunities? What risks are we missing? Your team scrambles to analyze data that should already be intelligence.

WHAT ANALYZER DELIVERS:

• Status Report Synthesis – Transforms project data into executive briefings with performance benchmarking, competitive analysis, and resource optimization recommendations.
• Strategic Document Intelligence – Analyzes strategic plans, clinical documents, and regulatory filings to extract competitive positioning, risk assessment, and implementation guidance.
• Portfolio Analytics – Synthesizes cross-project data to identify patterns, optimization opportunities, and strategic priorities across your entire portfolio.
• Industry Context Integration – Grounds every analysis in the current competitive landscape, regulatory precedent, and market intelligence—not isolated metrics.

THE OUTCOME:

Executive reviews focus on strategic decisions, not data presentation. Your board sees how programs compare to industry benchmarks and competitors. Strategic documents are analyzed for risks before they materialize. Portfolio optimization opportunities surface automatically from pattern analysis. Leadership makes informed decisions with competitive intelligence baked in. You deliver insight, not information.

WHO ANALYZER HELPS:

C-Suite Executives and Portfolio Leaders who need strategic intelligence synthesized from their data—not more dashboards that obscure what matters.

THE PROBLEM:

You're defending a $300M portfolio allocation with wildly different risk profiles—early discovery programs, late-stage pivots, platform investments, acquisitions. The board wants to know: What's the probability we hit $500M revenue? What if the Phase 3 fails? How correlated are these investments? Finance wants NPV projections. Investors want Monte Carlo simulations showing downside scenarios. Your spreadsheets show static point estimates that ignore technical risk, market uncertainty, and correlation effects. Leadership needs credible financial intelligence to make billion-dollar decisions, not back-of-envelope calculations.

WHAT FINANCIER DELIVERS:

• Risk-Adjusted NPV Modeling – Calculates rNPV with stage-gate probabilities across technical, regulatory, and commercial milestones—not blind NPV optimism.
• Monte Carlo Simulation – Quantifies uncertainty with probability distributions showing best-case, worst-case, and most-likely scenarios across thousands of iterations.
• Portfolio Correlation Analysis – Identifies which projects move together and which provide true diversification—optimizing risk-adjusted returns.
• Competitive Benchmarking – Grounds valuations in recent deal comparables, market multiples, and acquisition precedents from your therapeutic areas.

THE OUTCOME:

Board meetings shift from defending assumptions to discussing strategy. Your investment committee sees the 20% probability scenario alongside the 80% scenario—making decisions with eyes open. Portfolio allocation is optimized for risk-adjusted returns, not gut feel. When acquisitions are proposed, you evaluate them with the same rigor as internal programs. Capital flows to opportunities with the best risk-return profiles.

WHO FINANCIER HELPS:

Portfolio VPs and CFOs allocating capital across uncertain investments who need financial models that quantify risk with market intelligence—not hide it with static assumptions.

THE PROBLEM:

You're staring at 25 projects requesting $450M when you have $300M. Your team has 520 FTEs but projects demand 840. Every program head insists their project is critical. Leadership wants maximum risk-adjusted returns while the CFO demands cuts. Portfolio meetings become political battles where the most persuasive advocates win, not necessarily the best projects. You know there's an optimal combination that maximizes value, but you're trapped in spreadsheet paralysis. You need algorithms, not arguments.

WHAT OPTIMIZER DELIVERS:

• Multi-Scenario Portfolio Optimization – Generates 5+ optimal portfolio configurations using Modern Portfolio Theory to maximize risk-adjusted returns within your constraints.
• Resource Constraint Modeling – Incorporates budget limits, FTE capacity, and strategic priorities to identify feasible portfolios that respect real-world boundaries.
• Correlation and Diversification Analysis – Accounts for how projects interact—avoiding concentrated risk while maximizing diversification benefits.
• Stress Testing – Evaluates portfolio resilience across 7 disruption scenarios (budget cuts, resource constraints, market shifts) to assess robustness.

THE OUTCOME:

Portfolio decisions backed by optimization algorithms, not political horse-trading. Your leadership team evaluates 5 scientifically optimal scenarios—each maximizing different objectives (max NPV, max diversification, balanced risk-return). You see which projects make the cut under different constraints and why. Resource allocation becomes defensible with data—"here's why this combination maximizes value." Political pressure gives way to optimization intelligence.

WHO OPTIMIZER HELPS:

Portfolio VPs managing resource-constrained portfolios who need optimization intelligence to maximize risk-adjusted value—not political compromise.

THE PROBLEM:

You're juggling 15 programs. Every Monday, your coordinators spend half the day chasing updates: emails, Slack messages, Teams pings—"What's your status?" By Wednesday, you've collected maybe 60% of responses. Your dashboards are perpetually outdated because manual entry can't keep pace. Friday's steering meeting uses Tuesday's data. Critical tasks slip because no one reminded the owner their deadline is tomorrow. Dependencies block work but you don't know until someone escalates after the delay. Your coordinators are overwhelmed managing just 3-4 programs each. You can't scale without adding headcount.

WHAT COORDINATOR DELIVERS:

• Automated Status Collection – Proactively reaches out to task owners for progress updates before you ask, gathering detailed context on completion, blockers, and timeline concerns.
• Smart Deadline Nudges – Sends intelligent reminders before upcoming deadlines based on task priority and owner workload, preventing last-minute surprises.
• Real-Time Progress Tracking – Monitors task completion across all active projects and surfaces missed updates or delays immediately for escalation.
• Blocker Detection – Identifies dependencies blocking downstream work and alerts both task owners and program managers while corrective action is still possible.

THE OUTCOME:

Each coordinator manages 30+ programs with the same effort previously required for 3. Your dashboards show real-time progress—Friday's meeting uses Friday's data. Team members stay on track with proactive deadline reminders instead of reactive panic. Blockers surface Tuesday with corrective options, not Friday as post-mortems. Steering meetings focus on strategic decisions, not "why didn't we know about this delay?" Your coordination infrastructure scales with growth, not against it.

WHO COORDINATOR HELPS:

PMO Leaders managing portfolio growth who need coordination that scales through automation—not adding headcount for every new program.